Home > Journals > Minerva Anestesiologica > Past Issues > Articles online first > Minerva Anestesiologica 2020 Sep 22

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Anestesiologica 2020 Sep 22

DOI: 10.23736/S0375-9393.20.14592-9

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Sublingual sufentanil tablet system for the management of acute postoperative pain in a hospital setting: an observational study

Marco SCARDINO 1 , Alessandro TARTARELLI 2, Flaminia COLUZZI 3, Antonio CORCIONE 4, Ferdinando L. LORINI 5, Vito TORRANO 6, Pietro P. MARTORANO 7, Stefano QUAINI 8

1 Ortho Center, Humanitas Research Hospital, Milan, Italy; 2 Anesthesia Service, Casa Di Cura San Camillo, Forte dei Marmi, Lucca, Italy; 3 Unit of Anesthesia, Intensive Care and Pain Medicine, Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Latina, Italy; 4 Department of Critical Care Area, A.O. Ospedali dei Colli, Monaldi Hospital, Naples, Italy; 5 Emergency Department, ASST Papa Giovanni 23, Bergamo, Italy; 6 Anesthesia, Intensive Care and Pain Therapy, AO di Lodi, Lodi, Italy; 7 Neuroanesthesia Unit, Ospedali Riuniti, Ancona, Italy; 8 Anesthesia Service, Casa di Cura Villa Igea, Acqui Terme, Alessandria, Italy


PDF


BACKGROUND: The use of a strong opioid with intravenous patient-controlled analgesia (IV-PCA) is recommended for postoperative pain, but its use is restricted due to technical problems. Other delivery systems, like sublingual PCA, with the sufentanil tablet system (SSTS) device, could overcome the safety concerns related to IV-PCA.
METHODS: This prospective observational study evaluated the efficacy, safety and usability of SSTS for post-surgical analgesia in the real-life setting.
RESULTS: 298 (125 males) subjects, ranging 18−87 years who were undergoing a surgical intervention with a necessity for postoperative analgesia in a hospital setting, were analyzed for SSTS efficacy and safety. The primary end point (success of treatment according to Patient Global Assessment of the Method of Pain Control [PGA] on the second postoperative day) was achieved in 89.8% (95% CI: 85.6-93.1%, p≤0.001 from a presumed value of 60%). During the first 24 hours, pain was below the baseline score (1.2±1.4 after 4 hours and 1.8 ± 1.6 after 20 hours). The mean impairment in quality of sleep was 1.7±1.7 on postoperative day 1. The overall nurse ease of care (EOC) and nurses’ satisfaction questionnaire score was 4.6±0.6, and 4.1±0.9, respectively. The overall patient EOC score was 4.3±0.5; 93.5% patients were extremely satisfied/satisfied with pain control and 93.2% were extremely satisfied/satisfied with the way of the administration.
CONCLUSIONS: Under a real-life clinical practice setting, SSTS provides effective pain management and is easy to use for patients and nurses.


KEY WORDS: Postoperative pain; SSTS; Opioid, sufentanil

top of page